In South East Europe, penalties for drug offences remain high, although some efforts are being made to reduce penalties for drug use and possession. More recently however, governments have responded to increasing levels of NPS use with strong law enforcement efforts. In parallel, the economic crisis has had a devastating effect on the availability of harm reduction programmes.
The EMCDDA publishes a report providing an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area.
This paper explores areas for future development outlining the key implications for those engaged in planning or delivering health and social care responses to illicit drug use, specifically in relation to ageing drug users.
The EMCDDA offers an overview on naloxone access in the European Union and summarises the effectiveness of hand-out naloxone programmes to save the lives of people at risk of overdosing as well as giving recommendations for the future.